Annals On Call - Procalcitonin in the Diagnosis of Bacterial Infection

Web ExclusivesMarch 2022Annals On Call - Procalcitonin in the Diagnosis of Bacterial InfectionFREERobert M. Centor, MD and David N. Gilbert, MDRobert M. Centor, MDHuntsville Regional Medical Campus, University of Alabama Birmingham School of Medicine, Birmingham, Alabama (R.M.C.)Search for more papers by this author and David N. Gilbert, MDProvidence Medical Center, Portland, Oregon (D.N.G.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/A21-0006 CME/MOC SectionsAboutVisual Abstract ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In this episode of Annals On Call, Dr. Centor discusses the use of procalcitonin in the diagnosis of pneumonia with Dr. David Gilbert.Annals articles discussed include...Annals for Hospitalists Inpatient Notes - A Critical Look at Procalcitonin Testing in Pneumonia: https://www.acpjournals.org/doi/10.7326/M21-1913About Annals On CallAnnals On Call focuses on a clinically influential article published in Annals of Internal Medicine. Dr. Robert Centor shares his own perspective on the material and interviews topic area experts to discuss, debate, and share diverse insights about patient care and health care delivery.For more information on Annals On Call and for more episodes, visit go.annals.org/OnCall. Comments0 CommentsSign In to Submit A Comment Christine Laine, MD, MPHAnnals of internal Medicine, American College of Physicians5 August 2022 Response to Dr. Frick In response to Dr. Frick, note that disclosures of interest are available on Annals.org for every Annals on Call podcast by clicking the link under the podcast title. Disclosures: Dr. Laine is Editor in Chief, Annals of Internal Medicine and a full time employee of the American College of Physicians. Fred W Frick,MD,FACPCommunity Physicians of Indiana1 August 2022 Podcast on procalcitonin I would like Dr. Centor to take another look at procalcitonin. Some investigators, with no financial conflict with the owners of the procalcitonin test, have come to different conclusions. I am not implying that the podcast guest had any conflicts (I don't recall, was there a disclosure?), but a significant portion of the literature favorable to the test comes from investigators with financial conflicts. Author, Article, and Disclosure InformationAffiliations: Huntsville Regional Medical Campus, University of Alabama Birmingham School of Medicine, Birmingham, Alabama (R.M.C.)Providence Medical Center, Portland, Oregon (D.N.G.)Disclosures: Dr. Centor reports consulting fees from DynaMed and employment with the U.S. Department of Veterans Affairs. Dr. Gilbert reports research grants from BioFire, consulting fees from bioMérieux, and participation as chair of the data safety monitoring board for Leonard-Meron Biosciences. All relevant financial relationships have been mitigated. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=A21-0006.Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Stephanie Chang, MD, MPH, Deputy Editor, reports employment with the Agency for Healthcare Research and Quality, travel compensation from the Guidelines International Network, and participation in the Patient-Centered Outcomes Research Institute methodology committee. Vineet Chopra, MD, MSc, Deputy Editor, reports grants received from the Agency for Healthcare Research and Quality and royalties from UpToDate and Oxford University Press. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interests to disclose. Eliseo Guallar, MD, MPH, DrPH, Deputy Editor, Statistics, reports that he is employed at Johns Hopkins University. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center and consultancy with Boston Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports employment with the Perelman School of Medicine, University of Pennsylvania, and consultancies with the U.S. Food and Drug Administration and the State of Colorado.This article was published at Annals.org on 1 March 2022. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoAnnals for Hospitalists Inpatient Notes - A Critical Look at Procalcitonin Testing in Pneumonia Michael S. Pulia and Peter K. Lindenauer Metrics March 2022Volume 175, Issue 3Page: OC1 ePublished: 1 March 2022 Issue Published: March 2022 CopyrightCopyright © 2022 by American College of Physicians. All Rights Reserved.Loading ...